The Swiss pharmaceutical firm says the acquisition would complement its current pipeline of therapies for neuromuscle problems.
Source link
Novartis Agrees to Acquire Avidity Biosciences for $12 Billion
Related Posts
Why Is It So Hard to Fix an Electric Bike? (2026)
When you Ask any bike store proprietor or supervisor in the event that they repair electric bikes, you get an…
5 things to know before the stock market opens Monday
Wall Road and Broad St. indicators are seen as New York Inventory Trade constructing adorned for Christmas on the Monetary…
Meet the ‘Mad Max’-Loving CEO Challenging Nvidia With a Renegade Chip
June Paik spurned a takeover provide from Meta Platforms final yr. Now his firm, Furiosa, has an AI chip coming…